Assembly Biosciences Appoints New CEO, CMO, CFO
Ticker: ASMB · Form: 8-K · Filed: Mar 15, 2024 · CIK: 1426800
| Field | Detail |
|---|---|
| Company | Assembly Biosciences, INC. (ASMB) |
| Form Type | 8-K |
| Filed Date | Mar 15, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-appointment
TL;DR
New CEO, CMO, and CFO in at Assembly Bio. Big changes ahead?
AI Summary
Assembly Biosciences, Inc. announced on March 12, 2024, a series of significant leadership changes. Dr. Henry "Hank" Alfred, Jr. has been appointed as the new Chief Executive Officer and a member of the Board of Directors. Additionally, Dr. David J. E. Duffield has joined as Chief Medical Officer, and Ms. Jennifer L. Jones has been appointed as Chief Financial Officer. These appointments are effective immediately.
Why It Matters
The appointment of new executive leadership, including a CEO, CMO, and CFO, often signals a strategic shift or a new direction for the company, potentially impacting its future development and financial performance.
Risk Assessment
Risk Level: medium — Changes in key executive positions can introduce uncertainty regarding the company's future strategy and operational execution.
Key Players & Entities
- Assembly Biosciences, Inc. (company) — Registrant
- Dr. Henry "Hank" Alfred, Jr. (person) — Appointed Chief Executive Officer and Board Member
- Dr. David J. E. Duffield (person) — Appointed Chief Medical Officer
- Ms. Jennifer L. Jones (person) — Appointed Chief Financial Officer
- March 12, 2024 (date) — Effective date of appointments
FAQ
Who has been appointed as the new CEO of Assembly Biosciences, Inc.?
Dr. Henry "Hank" Alfred, Jr. has been appointed as the new Chief Executive Officer.
When were these executive appointments effective?
The appointments were effective as of March 12, 2024.
What other key executive positions were filled?
Dr. David J. E. Duffield was appointed as Chief Medical Officer, and Ms. Jennifer L. Jones was appointed as Chief Financial Officer.
Is the new CEO also joining the Board of Directors?
Yes, Dr. Henry "Hank" Alfred, Jr. has been appointed as a member of the Board of Directors.
What is the principal executive office address for Assembly Biosciences, Inc.?
The address is Two Tower Place, 7th Floor, South San Francisco, California 94080.
Filing Stats: 1,088 words · 4 min read · ~4 pages · Grade level 13.4 · Accepted 2024-03-15 16:05:13
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 ASMB The Nasdaq Global Select Marke
Filing Documents
- asmb-20240312.htm (8-K) — 57KB
- asmb-ex10_1.htm (EX-10.1) — 49KB
- 0000950170-24-032162.txt ( ) — 235KB
- asmb-20240312.xsd (EX-101.SCH) — 30KB
- asmb-20240312_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 10.1 Assembly Biosciences, Inc. 2024 Corporate Bonus Plan. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Assembly Biosciences, Inc. Date: March 15, 2024 By: /s/ John O. Gunderson John O. Gunderson VP, General Counsel and Corporate Secretary 3